MCMelina Claussnitzer

Melina Claussnitzer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melina Claussnitzer has a total of 563 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Human Genetics of Adipose Dysfunction: Genomic Mechanisms and Therapeutic Opportunities in Cardiometabolic Disease

    by Elizabeth A. Burton, Victor Svenstrup, Mayank Murali, Hesam Dashti, Ruth J.F. Loos, Melina Claussnitzer

    Cardiometabolic diseases are a leading cause of global morbidity and mortality and arise from shared and distinct risk factors acting through interconnected biological pathways. Although excess adiposity is a major risk factor, body mass index incompletely captures cardiometabolic risk, reflecting heterogeneity in overall and regional fat storage capacity and ectopic lipid accumulation. Failure of subcutaneous adipose tissue to expand appropriately promotes lipid overflow into visceral and ectopic depots, contributing to insulin resistance, dyslipidemia, and organ dysfunction. Human genetic studies have identified thousands of genetic loci influencing fat storage, fat distribution, and ectopic lipid accumulation, revealing that these traits reflect distinct underlying mechanisms with divergent cardiometabolic consequences. Recent scaling of genetic discovery for refined adiposity and cardiometabolic phenotypes and multitrait genetic approaches have advanced understanding of adipose-driven disease heterogeneity. We highlight variant-to-function strategies to resolve causal pathways and discuss emerging scalable approaches to accelerate biological learning from genetic discovery and translate these insights into adipose-directed therapeutics for cardiometabolic disease.

  • Open Access

    Transcriptional and epigenomic analysis of insulin sensitivity in human adipocytes

    by Qianbin Zhang, Audrey Zhou, Adam G. Maynard, Margo P. Emont, Christopher Jacobs, Soumya Nagesh, Thiago M. Batista, Renee M. Gibson, Yi Huang, Rama Kaalia, et al.

  • Open Access

    sc-pcQTL: hurdle-based co-expression modeling for multi-gene QTL mapping in single-cell RNA-seq data

    by Junkai Zhang, Yi Huang, Melina Claussnitzer, Masahiro Kanai, Wei Zhou

    Motivation: Single-cell expression quantitative trait locus (eQTL) studies can resolve cell-type-specific genetic effects, but conventional gene-by-gene analyses do not directly capture coordinated genetic regulation of neighboring genes. Principal-component QTL (pcQTL) mapping can summarize such multi-gene effects, but existing approaches were developed for bulk expression and are not designed for sparse single-cell counts. Results: We developed sc-pcQTL, a framework that applies two-component hurdle modeling and sliding-window clustering to identify local co-expression clusters, summarizes each cluster using principal components, and maps cis-pcQTLs. In simulations, the individual hurdle components controlled type I error, while the component-union screening rule was substantially more powerful than donor-level pseudobulk correlation tests. Applied to 1.24 million peripheral blood mononuclear cells from 982 OneK1K donors across 10 cell types, sc-pcQTL identified 2,485 local co-expression clusters and conducted QTL mapping for 4,353 cluster-PC phenotypes at single-cell resolution, of which 2,040 had at least one significant cis-pcQTL association. Fine-mapping and colocalization with genome-wide association study loci across 1,163 phenotypes in the FinnGen study identified 394 colocalized QTL-GWAS signal groups. Each group comprised fine-mapped QTL and GWAS signals connected through one or more colocalization links within the same cell type and local gene cluster. Of these groups, 46 were pcQTL-specific and contained no colocalized single-gene eQTL from a constituent gene. Locus-level analyses further revealed cell-type-specific multi-gene regulatory effects. Thus, sc-pcQTL complements conventional single-gene eQTL analysis by identifying trait-relevant regulatory signals shared across neighboring genes. Availability and implementation: The sc-pcQTL software is openly available at https://github.com/ZhouLabGenetics/sc-pcQTL ; analysis and figure-generation scripts are available at https://github.com/ZhouLabGenetics/sc-pcQTL_code ; and the summary result tables are publicly available on Zenodo (DOI: https://doi.org/10.5281/zenodo.21222687 ). Contact: wzhou@broadinstitute.org Supplementary material: Supplementary material accompanies this preprint.

  • Open Access

    Metabolic disease-relevant stimuli unmask context-dependent genetic regulation of cardiometabolic loci in human adipocytes

    by Yi Huang, Joaquin Perez-Schindler, Sanchari Datta, Yijia Christiana Liu, Bellis Min, Mayank Murali, Renee M. Gibson, Adam G. Maynard, Nivedita Nambrath, Phil Kubitz, et al.

    Genome-wide association studies (GWAS) have identified thousands of loci associated with cardiometabolic disease, yet translating these associations into regulatory mechanisms, effector genes, and cellular programs remains a major challenge. A key limitation is that genetic effects are often highly context dependent, varying across cell states and environmental conditions that are difficult to model at scale. Here, we leverage CellGenBank, a population-scale biobank of primary human adipose-derived mesenchymal stem cells (AMSCs), to implement a multi-donor cell village in vitro system to map cardiometabolic disease genetic variation across adipocyte differentiation and metabolic stress conditions. We pooled AMSCs from 118 donors into multiplexed villages, differentiated them toward adipocytes, and profiled chromatin accessibility and gene expression using single-nucleus multiome sequencing under four disease-relevant conditions: basal, elevated free fatty acids, low glucose, and hypoxia. By combining with genetic demultiplexing, we quantify how regulatory element activity, gene expression, and higher-order cellular programs are modulated by both genotype and environmental context. Across conditions, we identify widespread context-specific cis-regulatory effects, including expression and chromatin accessibility quantitative trait loci that are masked in baseline states. Genetic effects frequently converge on coordinated transcriptional programs linked to lipid metabolism, insulin responsiveness, and stress adaptation, enabling the identification of cellular program QTLs that bridge variants, genes, and disease-relevant phenotypes. Integration with cardiometabolic GWAS reveals enhanced colocalization in condition- and state-resolved analyses, highlighting the importance of modeling environmental context to resolve disease mechanisms. Together, our study establishes large-scale adipocyte cell villages as a powerful and generalizable framework to map the context-dependent regulatory architecture of cardiometabolic disease and provides a resource linking human genetic variation to adipocyte cellular programs.

  • Open Access

    Scalable context-dependent single-cell eQTL mapping reveals disease-relevant regulatory variation beyond static models

    by Yijia Christiana Liu, Anna S.E. Cuomo, Yi Huang, Joaquin Perez-Schindler, Bellis Min, Sanchari Datta, Nivedita Nambrath, Linfeng Hu, Kisung Nam, Masahiro Kanai, et al.

    Many disease-associated variants are thought to act through gene regulation, yet conventional eQTL mapping explains only a fraction of GWAS loci, potentially because regulatory effects vary across cellular states and environments. We present CASTIE, a scalable Poisson mixed-model framework that directly models sparse single-cell read counts and enables genome-wide testing of genotype-by-context interactions without pre-screening for static effects. Applying CASTIE to 1.2 million peripheral blood mononuclear cells from 982 OneK1K donors identified 3,155 context-dependent eQTL associations, including 2,022 eGenes without detectable static effects. These associations yielded 374 colocalizations across 94 traits, representing 270 unique loci, of which 197 were not recovered using the corresponding static eQTLs. The colocalizations linked trait associations to specific cellular contexts and genes including GCHFR , RNASET2 and ATP1A3 . In adipose-derived mesenchymal stem cells exposed to metabolic stimulations, CASTIE increased eGene discovery by 36-92% across cell populations and identified stimulation-dependent regulatory effects at metabolic trait loci. Thus, modeling cellular context reveals disease-relevant regulatory variation beyond static eQTL mapping.


  • Open Access

    TEscape: Defining the human transposable element transcriptome using multiplatform long-read sequencing

    by Rafael L. V. Mercuri, Daniela M. Mombach, Felipe R. C. dos Santos, Joaquin Perez-Schindler, Yi Huang, Pieter Spealman, Greta Pintacuda, Aziz Al'Khafaji, Elisa R. Donnard, Melina Claussnitzer, et al.

    Transposable elements (TEs) not only account for half of the human genome sequence but also generate transcripts that contribute to transcriptomic diversity. Yet, their repetitive nature has hindered accurate quantification of the full TE-derived transcriptome, a challenge that long-read sequencing can overcome. Here, we combined multiplexed arrays isoform sequencing (MAS-ISO-seq) with a dedicated computational framework (TEscape) to perform an in-depth annotation of the human TE transcriptome. To capture the breadth of human transcriptome diversity, we profiled six representative cell types spanning three distinct biological contexts, including metabolism with, primary patient-derived adipogenic cells at two differentiation stages, and iPSC derived hepatic progenitor cells; the nervous system with iPSC-derived neurons, neural progenitor cells (NPCs), and pluripotency using induced pluripotent stem cells (iPSCs). Together, these datasets yielded over 235 million full-length long reads. First, to assess data coverage and transcriptome depth, we quantified protein-coding gene expression, detecting 14,312 genes (73.6% of all annotated protein-coding genes), which is a level consistent with deep and comprehensive transcriptome representation. Second, focusing on TE-derived transcripts, we identified >83,000 previously unannotated isoforms, the vast majority (84%) originating from a complex combination of multi-TEs. We also identified solo TEs, which are predominantly from LINE1 (14%). We confirmed that TE-transcripts are able to be exemplified by signatures detected in Liver Hepatocellular Carcinoma (LICH). Together, MAS-ISO-seq and TEscape establish the first long-read-based, high-resolution atlas of transcribed human TEs, providing a foundational resource for integrative transcriptome analyses and for investigating TE expression and regulation in health and disease.


  • Open Access

    Inhibition of ceramide synthesis ameliorates body wasting in a cancer cachexia model

    by Pauline Morigny, Honglei Ji, Laura Cussonneau, Sabrina Zorzato, Yun Kwon, Fabien Riols, Doris Kaltenecker, Alisa Maier, Vignesh Karthikaisamy, Samantha Corrà, et al.

    Cachexia is a metabolic wasting syndrome affecting many patients with cancer, with poor survival outcomes. Disturbed lipid metabolism is a hallmark of cachexia, and our previous work has identified increased levels of circulating ceramides, which are bioactive lipids with adverse effects in metabolic diseases, as biomarkers for cachexia in mouse models and patients. Here, we investigated the role of ceramides on cachexia development using the well-established C26 colon carcinoma model. We demonstrated that elevated ceramides in cachexia arose from increased liver synthesis. We showed that ceramides directly contributed to impaired mitochondrial function and energy homeostasis in cachexia target tissues. Targeting ceramide synthesis using miRNA interference, or myriocin, an approved compound targeting the key synthesis enzyme serine palmitoyltransferase (SPT), improved markers of muscle atrophy in cachectic male mice. Importantly, we demonstrated that key enzymes involved in ceramide production were also elevated in livers, but not in other organs, of patients with cancer cachexia, correlating with disease severity. Our data place ceramides as contributors to metabolic dysfunction in cachexia and highlight the suitability of the ceramide synthesis pathway for therapeutic targeting. High circulating ceramides define cancer cachexia in mice and patients. Targeting ceramide synthesis counteracts mitochondrial dysfunction, impaired energy homeostasis and muscle atrophy in cachectic mice.


  • Open Access

    Genome-Wide Discovery Reveals Adipose-Specific and Systemic Regulators of Insulin Resistance

    by Mario Garcia-Urena, Pearlyn Jia Ying Toh, Raquel Sanz Martinez, Rama Kaalia, Mayank Murali, Hesam Dashti, Yaxin Jing, Cesar A. V. Cunha, María Jose Romero-Lado, Yuejiao Huang, et al.

    Insulin resistance (IR) is a key driver of cardiometabolic disease, yet its genetic and regulatory architecture remains incompletely understood. We performed a multi-trait GWAS of fasting insulin, triglycerides, and HDL cholesterol (n ≤ 1.25 million), identifying 282 IR-associated loci, including 70 novel. Polygenic score analyses linked IR to an adverse fat distribution characterized by reduced subcutaneous and increased visceral and ectopic fat. Stratifying loci by BMI associations revealed biologically distinct variant subgroups with divergent regulatory activity during adipogenesis. Enhancer-to-gene mapping implicated 72 loci in adipose-specific regulation, including a novel LAMB1 locus, wherein knockdown enhanced adipogenesis in vitro. Coding variants in PLAUR and INPP5A implicated inflammatory and calcium signaling pathways, while Mendelian Randomization identified circulating KLK1 as a candidate causal mediator in hyperinsulinemia. Our findings refine the genetic landscape of IR, highlight adipose dysfunction as a central mechanism, and nominate new targets for mechanistic and therapeutic investigation.

  • Open Access

    Extensive enhancer crosstalk controls PPARG2 activation during adipogenesis

    by Anna Cetnarowska, Mette Hyldahl, Marcus Nygård, Hesam Dashti, Bo Vagner Hansen, Laura Kristine Holm, Kaja Madsen, Maria Stahl Madsen, Vallari Shukla, Esra Durmaz Mitchell, et al.

    Transcriptional master regulators drive cell fate transitions. Peroxisome proliferator-activated receptor γ (PPARγ) is the master regulator of adipogenesis, and its expression must therefore be tightly regulated and efficiently induced in response to adipogenic cues. Here we decipher the regulatory mechanisms of the highly connected enhancer community driving activation of the PPARG locus during adipocyte differentiation of human mesenchymal stem cells. By systematically deleting nine individual enhancers, spanning upstream, promoter-proximal, and downstream super-enhancer constituents, we demonstrate elaborate enhancer crosstalk in cis involving stabilization of C/EBPβ recruitment prior to chromatin remodeling. We show that the super-enhancer constituent E + 102 plays a dual role in cis crosstalk and feedback activation and is obligate for activation of PPARG expression. Non-coding genetic variants associated with cardiometabolic traits and predicted to regulate PPARG expression map to E + 102 and other essential enhancers in the community, thereby supporting the importance of these enhancers in human physiology and disease.


  • Top Cited Papers

    The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR

    by Daniel R. Tabet, Atina G. Coté, Megan C. Lancaster, Jochen Weile, Ashyad Rayhan, Iosifina Fotiadou, Nishka Kishore, Roujia Li, Da Kuang, Jennifer J. Knapp, et al.

    Variants in the familial hypercholesterolemia gene LDLR —the most important genetic driver of cardiovascular disease—can raise circulating low-density lipoprotein (LDL) cholesterol concentrations and increase the risk of premature atherosclerosis. Definitive classifications are lacking for nearly half of clinically encountered LDLR missense variants, limiting interventions that reduce disease burden. We tested the impact of ~17,000 (nearly all possible) LDLR coding variants on both LDLR cell-surface abundance and LDL uptake, yielding sequence–function maps that recapitulate known biochemistry, offer functional insights, and provide evidence for interpreting clinical variants. Functional scores correlated with hyperlipidemia phenotypes in prospective human cohorts and augmented polygenic scores to improve risk inference, highlighting the potential of this resource to accelerate familial hypercholesterolemia diagnosis and improve patient outcomes.